Dr. Alejandro Pla, M.D.
Nephrology (Kidney) (Nephrology Physician)
- Medicare participating
At a glance
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 411
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Nephrology Physician primary
FL license 97968
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Memorial Hospital West Pembroke Pines, FL
- Memorial Hospital Miramar Miramar, FL
- Memorial Hospital Pembroke Pembroke Pines, FL
- Palmetto General Hospital Hialeah, FL
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 411
- Services billed
- 8,945
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Dialysis services, per day, less than full month service (20 years or older) | 992 | 39 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 569 | 116 |
| Established patient office or other outpatient visit, 30-39 minutes | 188 | 86 |
| Home dialysis services per month (20 years or older) | 137 | 47 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 120 | 66 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 97 | 17 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 89 | 69 |
| New patient office or other outpatient visit, 45-59 minutes | 33 | 33 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Furosemide Other prescribers in Pembroke Pines, FL | 200 |
| Allopurinol Other prescribers in Pembroke Pines, FL | 131 |
| Veltassa (patiromer calcium sorbitex) | 124 |
| Lokelma (sodium zirconium cyclosilicate) Other prescribers in Pembroke Pines, FL | 86 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Pembroke Pines, FL | 85 |
| Velphoro (sucroferric oxyhydroxide) | 81 |
| Bumetanide Other prescribers in Pembroke Pines, FL | 79 |
| Carvedilol Other prescribers in Pembroke Pines, FL | 76 |
| Sevelamer Carbonate Other prescribers in Pembroke Pines, FL | 67 |
| Losartan Potassium Other prescribers in Pembroke Pines, FL | 57 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 22 payments worth $658 in total to this clinician.
| Novartis Pharmaceuticals Corporation | $293 |
|---|---|
| Ardelyx, Inc. | $179 |
| Akebia Therapeutics Inc | $139 |
| Mallinckrodt Hospital Products Inc. | $22.94 |
| Calliditas Therapeutics US Inc. | $22.85 |
| Food and Beverage | $647 |
|---|---|
| Education | $10.57 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Akebia Therapeutics Inc Dec 18, 2025 | Education Vafseo · Nephrology · in-kind | $10.57 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $122,665 in research payments for these studies, mostly to the institutions running them.
- Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Csl Behring · Recruiting · NCT05485961
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.